News - Medical and health professional investment - VC and PE investment business - Shenzhen Efung Investment Management Co. Ltd.

发布时间: 2026 - 08 - 01

Party Building Guides the Investment Path, Bayi Spirit Reflects Our Original Aspiration | EFUNG Capi

August 1, 2026The 99th Anniversary of the Founding of the Chinese People's Liberation ArmyOn this day, when military flags fly high and glory shines bright, EFUNG Capital extends its highest respect to all servicemen and women who have once donned military uniforms and defended our homeland, as well as to their families."A strong country must have a strong military, and only a strong military can ensure national security." Having weathered nearly a century of trials, the People's Army has advanced under the banner of the Party, forging an unbreakable iron bastion. For an inve...

浏览次数：2

查看详情>>

发布时间: 2026 - 08 - 01

EFUNG’s Glory | EFUNG Capital Claims Dual Top Honors at Rongzhong 2025-2026 Annual Industry Investme

Recently, Rongzhong officially released its 2025-2026 Annual Industry Investment Rankings. EFUNG Capital was honored as one of the "Best Investment Institutions in China's Healthcare Sector 2025-2026," and CEO Zhu Pai was named one of the "Best Investment Figures in China's Healthcare Sector 2025-2026."The 2026 Government Work Report, for the first time, places the biopharmaceutical industry on par with integrated circuits, aerospace, and low-altitude economy, explicitly designating it as an "emerging pillar industry." This is not merely an iterative updat...

浏览次数：3

查看详情>>

发布时间: 2026 - 07 - 30

Monthly Health Digest | July 2026

Recently, the General Office of the State Council officially issued the Guiding Opinions on Strengthening Supervision, Preventing Risks, and Promoting the High-Quality Development of Private Investment Funds (State Council Letter No. 54 2026).As a key policy document within the "1+N+X" regulatory framework for the private fund industry, Document No. 54 marks a major shift in private fund supervision — from "industry self-regulation" to "administrative supervision." It represents another significant restructuring of the industry's top-level regul...

浏览次数：3

查看详情>>

发布时间: 2026 - 07 - 29

Efung News | Six Portfolio Companies of Efung Capital Make the List! Adding National "Potential Unic

On July 9, at the 2026 Potential Unicorn Enterprise (Wuxi) Development Conference held in Wuxi, Jiangsu, Great Wall Strategy Consulting unveiled the GEI China Potential Unicorn Enterprise Research Report 2026, the seventh edition of this series. Six Efung Capital portfolio companies—TriArm Therapeutics, Shensi Biopharma, Meichuang Medical, Xunlu Biotech, Yinming Biotech, and Jiyin Biotech—were honored on the list.As a new economy consulting firm that pioneered the systematic research and release of unicorn enterprise reports in China, Great Wall Strategy Consulting has continuously resear...

浏览次数：3

查看详情>>